Placement Announced
Opus Genetics placement
US$5m raised
Announced 21 Apr 2026 · NASDAQ: IRD
Advisers
Opus Genetics
Issuer
Lead managers
Not disclosed
- Issuer
- Opus Genetics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Ophthalmology
Similar deals
- Chimeric Therapeutics placement (May 2025) May 2025 · US$4.2m · Biotech
- Liminatus Pharma equity raising Feb 2026 · US$4m · Biotech
- Neurizon Therapeutics placement (September 2025) Sep 2025 · US$3.3m · Biotech
- Silexion Therapeutics Corp equity raising US$2.5m · Biotech
- Apimeds Pharmaceuticals US equity raising Dec 2025 · US$10.9m · Pharma
Sources
- 21 Apr 2026 Sidley Represents Opus Genetics in US$155 Million Financing With Oberland Capital sidley.com
